{"id":"NCT00870467","sponsor":"Abbott","briefTitle":"A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis","officialTitle":"A Phase 3 Multi-Center, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Comparing Adalimumab and Placebo in Adult Japanese Subjects With Rheumatoid Arthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-03","primaryCompletion":"2011-03","completion":"2011-08","firstPosted":"2009-03-27","resultsPosted":"2012-04-05","lastUpdate":"2012-08-07"},"enrollment":334,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"BIOLOGICAL","name":"Double-blind adalimumab","otherNames":["ABT-D2E7, adalimumab, Humira"]},{"type":"DRUG","name":"Double-blind Placebo","otherNames":["Placebo"]},{"type":"BIOLOGICAL","name":"Open-label Adalimumab","otherNames":["ABT-D2E7","adalimumab","Humira"]},{"type":"BIOLOGICAL","name":"Open-labelAdalimumabRescue","otherNames":["ABT-D2E7","adalimumab","Humira"]}],"arms":[{"label":"DB Placebo","type":"PLACEBO_COMPARATOR"},{"label":"DB adalimumab","type":"EXPERIMENTAL"},{"label":"DB Adalimumab/OL Adalimumab","type":"EXPERIMENTAL"},{"label":"DB Placebo/OL Adalimumab","type":"EXPERIMENTAL"},{"label":"DB Adalimumab/RE OL Adalimumab","type":"EXPERIMENTAL"},{"label":"DB Placebo/RE OL Adalimumab","type":"EXPERIMENTAL"}],"summary":"To evaluate the potential of adalimumab to inhibit radiographic progression in joint destruction compared with placebo in adult Japanese subjects with recent onset of rheumatoid arthritis.","primaryOutcome":{"measure":"Change From Baseline in Modified Total Sharp X-Ray Score at Week 26","timeFrame":"Baseline, Week 26","effectByArm":[{"arm":"DB Adalimumab","deltaMin":1.5,"sd":6.07},{"arm":"DB Placebo","deltaMin":2.4,"sd":3.2}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":88,"countries":["Japan"]},"refs":{"pmids":["27338778","24441150"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":171},"commonTop":["Nasopharyngitis","Hepatic function abnormal","Alanine aminotransferase increased","Rash","Injection site reaction"]}}